Mehta, A; Beck, M; Elliott, P et al.
Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry dataLancet. Bd. 374. 2009 S. 1986-96
Kalkum, G; Macchiella, D; Reinke, J et al.
Enzyme replacement therapy with agalsidase alfa in pregnant women with Fabry disease.Eur J Obstet Gynecol Reprod Biol. Bd. 144. H. 1. 2009 S. 92-3
Lampe, C; Miebach, E; Kraemer, E et al.
ENZYME-REPLACEMENT THERAPY (ERT) IN MPS PATIENTS WITH CNS MANIFESTATIONMOLECULAR GENETICS AND METABOLISM. Bd. 98. H. 1-2. 2009 S. 64-64
Langer, D; Ingenbrandt, C; Wildhardt, G et al.
Epigenetic influences on the origin of intrauterine growth defectsMedizinische Genetik. Bd. 21. H. 1. 2009 S. 147
Knuf, M; Sutter, U
Erhöhtes Risiko für den plötzlichen Kindstod nach 6fach-Impfung?Internist Prax. Bd. 49. H. 4. 2009 S. 907-10
Aksakal, D; Schier, F; Huckstadt, T et al.
ESTABLISHING AN ANIMAL MODEL (PIGLETS) FOR EXAMINATION OF INTRA CARDIAC SHUNTING IN INFANCYACTA PAEDIATRICA. Bd. 98. 2009 S. 29-29
Schlander, M; Beck, M
Expensive drugs for rare disorders: to treat or not to treat? The case of enzyme replacement therapy for mucopolysaccharidosis VICurr Med Res Opin. Bd. 25. H. 5. 2009 S. 1285-93
Tertilt, C; Joh, J; Krause, A et al.
Expression of B-cell activating factor enhances protective immunity of a vaccine against Pseudomonas aeruginosaInfect Immun. Bd. 77. H. 7. 2009 S. 3044-55
Pintos-Morell, G; Beck, M
Fabry disease in children and the effects of enzyme replacement treatmentEur J Pediatr. Bd. 168. H. 11. 2009 S. 1355-63
Kampmann, C
Fascinating Early modern period. Reich, Erieden, Culture and Communication 1500-1800.ZEITSCHRIFT FUR HISTORISCHE FORSCHUNG. Bd. 36. H. 4. 2009 S. 678-680